These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34177016)

  • 1. Do Returnee Executives Value Corporate Philanthropy? Evidence from China.
    Zhang L; Xu Y; Chen H
    J Bus Ethics; 2022; 179(2):411-430. PubMed ID: 34177016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senior executive characteristics: Impact on ESG practices and corporate valuation relationship.
    Cai C; Geng Y; Yang F
    PLoS One; 2024; 19(7):e0303081. PubMed ID: 38990983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executives' academic experience and corporate social responsibility: A case study in China.
    Yang X; Qi M
    PLoS One; 2024; 19(6):e0305813. PubMed ID: 38917164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female CEO succession and corporate social disclosure in China: unveiling the significance of ownership status and firm performance.
    Shaheen R; Luo Q; Bala H
    Environ Sci Pollut Res Int; 2023 Feb; 30(6):14223-14239. PubMed ID: 36149559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?-Empirical Evidence From COVID-19.
    Li J; Ma Y; Shi B; Yang Y
    Front Public Health; 2021; 9():812253. PubMed ID: 35155358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Team Ownership and Philanthropy in Professional Sport: A Perspective on Organizational Generosity.
    Babiak K; Yang D
    Front Sports Act Living; 2022; 4():798919. PubMed ID: 35434620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family Sibling Effect and Executives' Corporate Social Behavior.
    Zheng M; Ren G; Zhuang L
    Front Psychol; 2021; 12():667529. PubMed ID: 34211422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEO Regulatory Focus, Analysts' Optimism Bias, and Firm Strategic Change: Evidence From Chinese-Listed Companies.
    Huang C; Zheng W
    Front Psychol; 2022; 13():813920. PubMed ID: 35401381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of senior executives' overseas experience on corporate green innovation.
    Cheng F; Kuang X
    PLoS One; 2024; 19(5):e0296716. PubMed ID: 38696492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-Firm Executive Mobility and Corporate Social Responsibility: Evidence From China.
    Wang J; Cao J
    Front Psychol; 2022; 13():904450. PubMed ID: 35719529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhance or inhibit? Unveiling the influence of chairman's hometown attachment on the corporate philanthropy-Corporate financial performance relationship.
    Chen L; Bu X
    Front Psychol; 2022; 13():956689. PubMed ID: 36438309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate strategic philanthropy: implications for social work.
    Marx JD
    Soc Work; 1998 Jan; 43(1):34-41. PubMed ID: 9508728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executives' ESG cognition and enterprise green innovation: Evidence based on executives' personal microblogs.
    Wang D; Luo Y; Hu S; Yang Q
    Front Psychol; 2022; 13():1053105. PubMed ID: 36544446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Officials' promotion expectation, corporate strategic deviance and corporate growth in China: The moderating effect of corporate ownership.
    Li Y; Fang X
    PLoS One; 2023; 18(8):e0284872. PubMed ID: 37624770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover at the Top: The Digital Transformation and Dismissal of Chairman and CEO.
    Qi J; Zhou Y; Lv W; Du Q; Liu R; Liu C
    Front Psychol; 2022; 13():883192. PubMed ID: 35586233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderating Effect of Chief Executive Officer Narcissism in the Relationship Between Corporate Social Responsibility and Green Technology Innovation.
    Yang H; Shi X; Wang S
    Front Psychol; 2021; 12():717491. PubMed ID: 34744876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executives' carbon cognition and corporate carbon performance: The mediating role of corporate low-carbon actions and the moderating role of firm size.
    Gao W; Wen S; Li H; Lyu X
    Heliyon; 2024 Jan; 10(1):e23959. PubMed ID: 38205311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.